Notions of synergy for combinations of interventions against infectious diseases in heterogeneously mixing populations

Mathematical Biosciences

Volumn 227, Issue 2, 2010, Pages 94-104

  Dodd, Peter J ^a   White, Peter J ^a,b   Garnett, Geoff P ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Endemic equilibria; HIV; Multiple interventions; R0; Synergy

Indexed keywords

ENDEMIC EQUILIBRIA; HIV; MULTIPLE INTERVENTIONS; R0; SYNERGY;

HEALTH RISKS;

MERGERS AND ACQUISITIONS;

DISEASE PREVALENCE; DISEASE SPREAD; EPIDEMIOLOGY; HUMAN IMMUNODEFICIENCY VIRUS; IMPLEMENTATION PROCESS; INFECTIOUS DISEASE; PUBLIC HEALTH; RISK FACTOR; STRATEGIC APPROACH;

ARTICLE; DISEASE MODEL; DISEASE TRANSMISSION; ENDEMIC DISEASE; EPIDEMIOLOGICAL DATA; HIGH RISK POPULATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION; INFECTION PREVENTION; INFECTION RISK; INFECTION SENSITIVITY; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; PREVALENCE; PREVENTIVE HEALTH SERVICE; PUBLIC HEALTH SERVICE; RISK ASSESSMENT; SEXUALLY TRANSMITTED DISEASE;

AIDS VACCINES; ALGORITHMS; BASIC REPRODUCTION NUMBER; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; DISEASE SUSCEPTIBILITY; ENDEMIC DISEASES; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; MODELS, BIOLOGICAL; POPULATION DYNAMICS; PREVALENCE; RISK; SEXUAL BEHAVIOR;

EID: 77956190610     PISSN: 00255564     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mbs.2010.06.004     Document Type: Article

References (30)

1. Abbas U., Anderson R., Mellors J. Potential impact of antiretroviral chemoprophylaxis on HIV-1 transmission in resource-limited settings. PLoS ONE 2007, 2(9):e875.
2. Anderson R., May R. Infectious Diseases of Humans 1991, Oxford University Press, New York.
3. R. Anderson, J. Swinton, G. Garnett, Potential impact of low efficacy HIV-1 vaccines in populations with high rates of infection, in: Proceedings: Biological Sciences, 1995.
4. Attia S., Egger M., Müller M., Zwahlen M., Low N. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS 2009, 23(11):1397.
5. Auvert B., Taljaard D., Lagarde E., Sobngwi-Tambekou J., Sitta R., Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRSr bailey, o egesah, and s rosenberg 1265 trial. Plos Med. 2005, 2(11):e298.
6. Bailey R., Egesah O., Rosenberg S. Male circumcision for HIV prevention: a prospective study of complications in clinical and traditional settings in Bungoma, Kenya. Bull. World Health Organ. 2008, 86(9).
7. Ball F., Becker N. Control of transmission with two types of infection. Math. Biosci. 2006, 200(2):170.
8. Desai K., Sansom S., Ackers M., Stewart S., Hall H., Hu D., Sanders R., Scotton C., Soorapanth S., Boily M.-C., Garnett G., McElroy P. Modeling the impact of HIV chemoprophylaxis strategies among men who have sex with men in the united states: HIV infections prevented and cost-effectiveness. AIDS 2008, 22(14):1829.
9. Diekmann O., Heesterbeek J. Mathematical Epidemiology of Infectious Diseases: Model Building, Analysis and Interpretation 2000, Wiley, Chichester.
10. Diekmann O., Heesterbeek J., Metz J. On the definition and the computation of the basic reproduction ratio R0 in models for infectious-diseases in heterogeneous populations. J. Math. Biol. 1990, 28(4):365.
11. Diekmann O., Heesterbeek J., Roberts M. The construction of next-generation matrices for compartmental epidemic models. J. Roy. Soc. Interface 2009, 7(47):873.
12. Garnett G. The influence of behavioural heterogeneity on the population level effect of potential prophylactic type 1 human immunodeficiency virus vaccines. J. Roy. Stat. Soc. A 1998, 161:209.
13. Granich R., Gilks C., Dye C., De Cock K., Williams B. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 2009, 373(9657):48.
14. Gray R., Kigozi G., Serwadda D., Makumbi F., Nalugoda F., Watya S., Moulton L., Chen M., Sewankambo N., Kiwanuka N., Sempijja V., Lutalo T., Kagayii J., Wabwire-Mangen F., Ridzon R., Bacon M., Wawer M. The effects of male circumcision on female partners' genital tract symptoms and vaginal infections in a randomized trial in Rakai, Uganda. Am. J. Obstet. Gynecol. 2009, 200(1):42.e1.
15. Heesterbeek J., Roberts M. The type-reproduction number T in models for infectious disease control. Math. Biosci. 2007, 206(1):3.
16. Hethcote H., Yorke J. Gonorrhea Transmission Dynamics and Control 1984, Springer, Berlin.
17. Hollingsworth T., Anderson R., Fraser C. HIV-1 transmission, by stage of infection. J. Infect. Dis. 2008, 198(5):687.
18. Lloyd-Smith J., Poss M., Grenfell B. HIV-1/parasite co-infection and the emergence of new parasite strains. Parasitology 2008, 135(7):795.
19. McLean A., Blower S. Imperfect vaccines and herd-immunity to HIV. Proc. Roy. Soc. Lond. B Bio. 1993, 253(1336):9.
20. Meyer C. Matrix Analysis and Applied Linear Algebra? 2000, SIAM.
21. Montaner J., Hogg R., Wood E., Kerr T., Tyndall M., Levy A., Harrigan P. The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet 2006, 368(9534):531.
22. Piot P., Bartos M., Larson H., Zewdie D., Mane P. Coming to terms with complexity: a call to action for HIV prevention. Lancet 2008, 372(9641):845.
23. Roberts M., Heesterbeek J. A new method for estimating the effort required to control an infectious disease. Proc. Roy. Soc. B Biol. Sci. 2003, 270(1522):1359.
24. Stover J., Bollinger L., Hecht R., Williams C., Roca E. The impact of an AIDS vaccine in developing countries: a new model and initial results. Health Affair 2007, 26(4):1147.
25. Todd J., Glynn J., Marston M., Lutalo T., Biraro S., Mwita W., Suriyanon V., Rangsin R., Nelson K., Sonnenberg P., Fitzgerald D., Karita E., Zaba B. Time from HIV seroconversion to death: a collaborative analysis of eight studies in six low and middle-income countries before highly active antiretroviral therapy. AIDS 2007, 21:S55.
26. Vissers D., Voeten H., Nagelkerke N., Habbema J., de Vlas S. The impact of pre-exposure prophylaxis (prep) on HIV epidemics in africa and india: A simulation study. PLoS ONE 2008, 3(5):e2077.
27. Weber J., Desai K., Darbyshire J. The development of vaginal microbicides for the prevention of HIV transmission. Plos Med. 2005, 2(5):392.
28. Weiss H., Halperin D., Bailey R., Hayes R., Schmid G., Hankins C. Male circumcision for HIV prevention: from evidence to action?. AIDS 2008, 22(5):567.
29. Wilson D. Data are lacking for quantifying HIV transmission risk in the presence of effective antiretroviral therapy. AIDS 2009, 23(11):1431.
30. Yates A., Antia R., Regoes R. How do pathogen evolution and host heterogeneity interact in disease emergence?. Proc. Roy. Soc. B 2006, 273(1605):3075.